(-)-8a-(4-bromophenyl)-1,8-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-3a-ol

Names and Identifiers

Canonical SMILES: CN1CC[C@@]2(O)c3ccccc3N(C)[C@@]12c1ccc(Br)cc1

Standard InChI: InChI=1S/C18H19BrN2O/c1-20-12-11-17(22)15-5-3-4-6-16(15)21(2)18(17,20)13-7-9-14(19)10-8-13/h3-10,22H,11-12H2,1-2H3/t17-,18-/m1/s1

Standard InChI Key: ABNPEHBZMJIFGP-QZTJIDSGSA-N

Molfile:

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   19.7075  -24.3888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1953  -23.7259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7141  -23.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9274  -24.1323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9356  -23.3155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1478  -24.3755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6768  -23.7092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1621  -23.0576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8439  -22.3115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0364  -22.2158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5483  -22.8722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8733  -23.6157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9275  -22.4934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9192  -24.9532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2013  -25.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1928  -26.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9007  -26.5933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6187  -26.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6238  -25.3646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8875  -25.1543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9562  -25.1672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8937  -27.4105    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  1  2  1  0
  2  3  1  0
  3  5  1  0
  4  5  1  0
  5  8  1  0
  7  6  1  0
  6  4  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  5 13  1  1
  4 14  1  1
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  6 20  1  0
  1 21  1  0
 17 22  1  0
M  END

Alternative Forms

Parent:

ALA4755418
---

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; alpha-1/beta-2/gamma-2 (1171 Activities)

Discover Target: GABRA1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Unknown	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 359.27	Molecular Weight (Monoisotopic): 358.0681	AlogP: 3.28	#Rotatable Bonds: 1
Polar Surface Area: 26.71	Molecular Species: NEUTRAL	HBA: 3	HBD: 1
#RO5 Violations: ┄	HBA (Lipinski): 3	HBD (Lipinski): 1	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: 12.81	CX Basic pKa: 5.50	CX LogP: 4.09	CX LogD: 4.08
Aromatic Rings: 2	Heavy Atoms: 22	QED Weighted: 0.85	Np Likeness Score: 0.57

References

1. Blom AEM,Su JY,Repka LM,Reisman SE,Dougherty DA. (2020) Synthesis and Biological Evaluation of Pyrroloindolines as Positive Allosteric Modulators of the α1β2γ2 GABA Receptor., 11 (11): [PMID:33214830] [10.1021/acsmedchemlett.0c00340]

Source

Source(1):

Scientific Literature